1. Home
  2. RNXT

RNXT

RenovoRx Inc.

Logo RenovoRx Inc.

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-12-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

RenovoRx Inc is a clinical-stage biopharmaceutical company. It is focused on developing therapies for the local treatment of solid tumors and conducting a Phase 3 pancreatic cancer clinical trial for its lead product candidate RenovoGem.

Founded: 2012 Country:
United States
United States
Employees: N/A City: SAN JOSE
Market Cap: 22.5M IPO Year: 2021
Target Price: $4.00 AVG Volume (30 days): 51.0K
Analyst Decision: Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.99 EPS Growth: N/A
52 Week Low/High: $0.53 - $3.29 Next Earning Date: 05-13-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: